Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scm polycomb group protein like 1 (SCML1) is a putative member of the Polycomb group (PcG) proteins, which are involved in forming multiprotein complexes to maintain the transcriptionally repressive state of target genes throughout development. It is predicted to enable chromatin and histone binding and functions as a transcriptional repressor, likely playing roles in germ cell nuclei, and may be involved in spermatogenesis. While deletion of the SCML1 locus can co-occur with developmental disorders, SCML1 itself is not currently considered a direct therapeutic or pharmacological target[1][8][9][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scm polycomb group protein like 1 (SCML1).